Pinovit nasal drops bottle 10 ml




Instructions for Pinovit nasal drops, bottle 10 ml
Composition
active ingredients: 1 ml of the drug contains mountain pine oil (Oleum Pini pumilionis) 35 mg, mint oil (Mentha oil) 10 mg, eucalyptus oil (Eucalypti oleum) 5 mg, α-tocopherol acetate 15 mg, thymol 0.3 mg;
excipients: medium chain triglycerides
Dosage form
Nasal drops.
Main physicochemical properties: transparent, colorless or slightly yellowish oily liquid with a specific odor.
Pharmacotherapeutic group
Decongestants and other drugs for topical use in the nasal cavity. Drugs used for diseases of the nasal cavity. Combined drugs.
ATX code R01A X30.
Pharmacological properties
Pharmacodynamics
Pinovit® has anti-inflammatory and anti-edematous effects, reduces the severity of local exudative reactions, reduces the viscosity of the secretion of the respiratory tract mucosa. The drug exhibits antibacterial activity against some strains of gram-positive and gram-negative bacteria, as well as antifungal activity against yeast and mold fungi.
Pharmacokinetics
Not studied.
Indication
Acute and chronic rhinitis of non-allergic etiology, rhinopharyngitis, infectious and inflammatory diseases of the nasal and nasopharyngeal mucosa, laryngotracheitis.
Contraindication
Allergic rhinitis, hypersensitivity to the components of the drug.
Interaction with other medicinal products and other types of interactions
Not described.
Application features
Before use, it is necessary to check the patient's individual reaction to the drug after a single instillation of Pinovit® into the nose. If allergic reactions develop, the drug should not be used.
Use the drug with caution in patients with severe liver disease.
Do not allow the drug to get into your eyes!
Ability to influence reaction speed when driving vehicles or other mechanisms
The use of the drug does not affect the ability to drive vehicles and work with other mechanical devices.
Use during pregnancy or breastfeeding
The drug in therapeutic doses can be used during pregnancy or breastfeeding.
Method of administration and doses
Immediately before use, hold the bottle with the drug in the palm of your hand to warm it to body temperature. Remove the cap and, slightly pressing on the rubber dropper insert, drip the solution into the nose. After using the drug, always close the bottle with the cap.
Adults. On the first day, instill 2-3 drops of Pinovit® into each nasal passage 3-6 times a day, from the second day - 2-3 drops into each nasal passage 3-4 times a day.
Children over 2 years old: 1-2 drops of the drug 3-4 times a day.
The duration of treatment is determined by the doctor individually, depending on the therapeutic effect and tolerability of the drug. Usually the course of treatment is 5-7 days.
Children
Pinovit® should be used in children over 2 years of age.
The drug should be used with caution in children due to the possibility of bronchospasm.
Overdose
There is no risk of overdose when used topically.
Adverse reactions
The table below summarizes the adverse reactions to Scots pine oil, peppermint oil, eucalyptus oil, α-tocopherol acetate and thymol, grouped according to MedDRA terminology and frequency: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000); frequency unknown (cannot be estimated from the available data):
Adverse reactions
Organ system | Frequency | |
Respiratory, thoracic and mediastinal disorders | rarely | Itching in the nose, burning in the nose, swelling of the nasal mucosa, bronchospasm; with prolonged use, dryness of the respiratory mucosa is possible |
On the part of the immune system | frequency unknown | hypersensitivity reactions, including skin rashes, flushing, angioedema, urticaria |
From the organs of vision | frequency unknown | eye irritation |
Skin and connective tissue disorders | frequency unknown | skin irritation, contact dermatitis |
Reporting possible adverse reactions
Reporting of possible adverse reactions after the registration of a medicinal product is an important procedure. It allows for the continued monitoring of the benefit/risk balance of a given medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.
Expiration date
2 years.
Do not use the drug after the expiration date indicated on the package.
Storage conditions
Store in a place protected from light at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging
10 ml in a bottle. 1 bottle in a pack.
Vacation category
Without a prescription.
Producer
PJSC "Farmak".
Location of the manufacturer and its business address
Ukraine, 04080, Kyiv, Kyrylivska St., 74.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.